EP300 gene has often been found to be mutated/truncated in lymphomas and different solid tumors, such as gastric, colorectal, breast, and pancreatic cancers, and over-expressed and correlated to poor prognosis in liver, nasopharyngeal, and small and non-small cell lung cancer [37]. This evidence concerns the gene EP300 and familial pancreatic carcinoma.